Download PDF
Clin Colon Rectal Surg 2012; 25(01): 012-019
DOI: 10.1055/s-0032-1301754
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Medical Management of Constipation

Meredith Portalatin
1   Department of Gastroenterology, Ochsner Clinic Foundation, New Orleans, Louisiana.
,
Nathaniel Winstead
1   Department of Gastroenterology, Ochsner Clinic Foundation, New Orleans, Louisiana.
› Author Affiliations
Further Information

Publication History

Publication Date:
23 March 2012 (online)

Also available at
    Permissions and Reprints

Abstract

Constipation is a common clinical problem. Initial management of chronic constipation should include lifestyle maneuvers, and increased fiber and fluids. Polyethylene glycol, sodium picosulfate, bisacodyl, prucalopride, lubiprostone, and linaclotide were all more effective than placebo for treating chronic idiopathic constipation. Many commonly used agents lack quality evidence supporting their use.

Keywords

constipation - laxatives - fiber - osmotic agents - polyethylene glycol - 5-ht4 agonists
 

  • References

  • 1 DiPalma JA. Current treatment options for chronic constipation. Rev Gastroenterol Disord 2004; 4 (Suppl 2) S34-S42
    PubMedGoogle Scholar
  • 2 Meshkinpour H, Selod S, Movahedi H, Nami N, James N, Wilson A. Effects of regular exercise in management of chronic idiopathic constipation. Dig Dis Sci 1998; 43 (11) 2379-2383
    CrossrefPubMedGoogle Scholar
  • 3 Young RJ, Beerman LE, Vanderhoof JA. Increasing oral fluids in chronic constipation in children. Gastroenterol Nurs 1998; 21 (4) 156-161
    CrossrefPubMedGoogle Scholar
  • 4 Locke III GR, Pemberton JH, Phillips SF. AGA medical position statement: guidelines on constipation. Gastroenterology 2000; 119 (6) 1761-1766
    CrossrefPubMedGoogle Scholar
  • 5 Voderholzer WA, Schatke W, Mühldorfer BE, Klauser AG, Birkner B, Müller-Lissner SA. Clinical response to dietary fiber treatment of chronic constipation. Am J Gastroenterol 1997; 92 (1) 95-98
    PubMedGoogle Scholar
  • 6 Anti M, Pignataro G, Armuzzi A , et al. Water supplementation enhances the effect of high-fiber diet on stool frequency and laxative consumption in adult patients with functional constipation. Hepatogastroenterology 1998; 45 (21) 727-732
    PubMedGoogle Scholar
  • 7 Schiller LR. Review article: the therapy of constipation. Aliment Pharmacol Ther 2001; 15 (6) 749-763
    CrossrefPubMedGoogle Scholar
  • 8 DiPalma JA, Brady III CE. Steakhouse spasm. J Clin Gastroenterol 1987; 9 (3) 274-278
    CrossrefPubMedGoogle Scholar
  • 9 Hamilton JW, Wagner J, Burdick BB, Bass P. Clinical evaluation of methylcellulose as a bulk laxative. Dig Dis Sci 1988; 33 (8) 993-998
    CrossrefPubMedGoogle Scholar
  • 10 Bass P, Clark C, DoPico GA. Comparison of the laxative efficacy and patient preference of calcium polycarbophil and psyllium suspension. Curr Ther Res 1988; 43: 770-774
    PubMedGoogle Scholar
  • 11 Lembo A, Camilleri M. Chronic constipation. N Engl J Med 2003; 349 (14) 1360-1368
    CrossrefPubMedGoogle Scholar
  • 12 Harvey RF, Read AE. Saline purgatives act by releasing cholecystokinin. Lancet 1973; 2 (7822) 185-187
    PubMedGoogle Scholar
  • 13 Izzo AA, Gaginella TS, Capasso F. The osmotic and intrinsic mechanisms of the pharmacological laxative action of oral high doses of magnesium sulphate. Importance of the release of digestive polypeptides and nitric oxide. Magnes Res 1996; 9 (2) 133-138
    PubMedGoogle Scholar
  • 14 DiPalma JA, Buckley SE, Warner BA, Culpepper RM. Biochemical effects of oral sodium phosphate. Dig Dis Sci 1996; 41 (4) 749-753
    CrossrefPubMedGoogle Scholar
  • 15 Toledo TK, DiPalma JA. Review article: colon cleansing preparation for gastrointestinal procedures. Aliment Pharmacol Ther 2001; 15 (5) 605-611
    CrossrefPubMedGoogle Scholar
  • 16 Bass P, Dennis S. The laxative effects of lactulose in normal and constipated subjects. J Clin Gastroenterol 1981; 3 (Suppl 1) 23-28
    CrossrefPubMedGoogle Scholar
  • 17 Schiller LR, Emmett M, Santa Ana CA, Fordtran JS. Osmotic effects of polyethylene glycol. Gastroenterology 1988; 94 (4) 933-941
    PubMedGoogle Scholar
  • 18 DiPalma JA, DeRidder PH, Orlando RC, Kolts BE, Cleveland MB. A randomized, placebo-controlled, multicenter study of the safety and efficacy of a new polyethylene glycol laxative. Am J Gastroenterol 2000; 95 (2) 446-450
    CrossrefPubMedGoogle Scholar
  • 19 Di Palma JA, Smith JR, Cleveland M. Overnight efficacy of polyethylene glycol laxative. Am J Gastroenterol 2002; 97 (7) 1776-1779
    CrossrefPubMedGoogle Scholar
  • 20 Klaschik E, Nauck F, Ostgathe C. Constipation—modern laxative therapy. Support Care Cancer 2003; 11 (11) 679-685
    CrossrefPubMedGoogle Scholar
  • 21 Tzavella K, Riepl RL, Klauser AG, Voderholzer WA, Schindlbeck NE, Müller-Lissner SA. Decreased substance P levels in rectal biopsies from patients with slow transit constipation. Eur J Gastroenterol Hepatol 1996; 8 (12) 1207-1211
    CrossrefPubMedGoogle Scholar
  • 22 Oster JR, Materson BJ, Rogers AI. Laxative abuse syndrome. Am J Gastroenterol 1980; 74 (5) 451-458
    PubMedGoogle Scholar
  • 23 Nusko G, Schneider B, Schneider I, Wittekind C, Hahn EG. Anthranoid laxative use is not a risk factor for colorectal neoplasia: results of a prospective case control study. Gut 2000; 46 (5) 651-655
    CrossrefPubMedGoogle Scholar
  • 24 Wald A. Chronic constipation: pathophysiology, diagnosis, and management. Gastrointest Dis Today 1997; 6: 8-17
    PubMedGoogle Scholar
  • 25 Talley NJ. Pharmacologic therapy for the irritable bowel syndrome. Am J Gastroenterol 2003; 98 (4) 750-758
    CrossrefPubMedGoogle Scholar
  • 26 Chapman RW, Sillery J, Fontana DD, Matthys C, Saunders DR. Effect of oral dioctyl sodium sulfosuccinate on intake-output studies of human small and large intestine. Gastroenterology 1985; 89 (3) 489-493
    PubMedGoogle Scholar
  • 27 McRorie JW, Daggy BP, Morel JG, Diersing PS, Miner PB, Robinson M. Psyllium is superior to docusate sodium for treatment of chronic constipation. Aliment Pharmacol Ther 1998; 12 (5) 491-497
    CrossrefPubMedGoogle Scholar
  • 28 Wagstaff AJ, Frampton JE, Croom KF. Tegaserod: a review of its use in the management of irritable bowel syndrome with constipation in women. Drugs 2003; 63 (11) 1101-1120
    CrossrefPubMedGoogle Scholar
  • 29 Schiller LR. New and emerging treatment options for chronic constipation. Rev Gastroenterol Disord 2004; 4 (Suppl 2) S43-S51
    PubMedGoogle Scholar
  • 30 Tack J, van Outryve M, Beyens G, Kerstens R, Vandeplassche L. Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives. Gut 2009; 58 (3) 357-365
    CrossrefPubMedGoogle Scholar
  • 31 Manini ML, Camilleri M, Goldberg M , et al. Effects of velusetrag (TD-5108) on gastrointestinal transit and bowel function in health and pharmacokinetics in health and constipation. Neurogastroenterol Motil 2010; 22 (1) 42-49, e7–e8
    PubMedGoogle Scholar
  • 32 Camilleri M, Bharucha AE, Ueno R , et al. Effect of a selective chloride channel activator, lubiprostone, on gastrointestinal transit, gastric sensory, and motor functions in healthy volunteers. Am J Physiol Gastrointest Liver Physiol 2006; 290 (5) G942-G947
    PubMedGoogle Scholar
  • 33 Yuan CS, Foss JF, O’Connor M , et al. Methylnaltrexone for reversal of constipation due to chronic methadone use: a randomized controlled trial. JAMA 2000; 283 (3) 367-372
    CrossrefPubMedGoogle Scholar
  • 34 Obokhare ID, Champagne B, Stein SL, Krpata D, Delaney CP. The effect of alvimopan on recovery after laparoscopic segmental colectomy. Dis Colon Rectum 2011; 54 (6) 743-746
    CrossrefPubMedGoogle Scholar
  • 35 Lembo AJ, Schneier HA, Shiff SJ , et al. Two randomized trials of linaclotide for chronic constipation. N Engl J Med 2011; 365 (6) 527-536
    CrossrefPubMedGoogle Scholar
  • 36 Coulie B, Szarka LA, Camilleri M , et al. Recombinant human neurotrophic factors accelerate colonic transit and relieve constipation in humans. Gastroenterology 2000; 119 (1) 41-50
    CrossrefPubMedGoogle Scholar
  • 37 Nurko S. Advances in the management of pediatric constipation. Curr Gastroenterol Rep 2000; 2 (3) 234-240
    CrossrefPubMedGoogle Scholar
  • 38 Baker SS, Liptak GS, Colletti RB , et al. Constipation in infants and children: evaluation and treatment. A medical position statement of the North American Society for Pediatric Gastroenterology and Nutrition. J Pediatr Gastroenterol Nutr 1999; 29 (5) 612-626
    CrossrefPubMedGoogle Scholar
  • 39 Gremse DA, Hixon J. Comparison of polyethylene glycol 3350, NF powder and lactulose for treatment of chronic constipation in children. J Pediatr Gastroenterol Nutr 2000; 31: S131
    PubMedGoogle Scholar
  • 40 Pashankar DS, Bishop WP. Efficacy and optimal dose of daily polyethylene glycol 3350 for treatment of constipation and encopresis in children. J Pediatr 2001; 139 (3) 428-432
    CrossrefPubMedGoogle Scholar
  • 41 Loening-Baucke VA. Polyethylene glycol without electrolytes for children with constipation and encopresis. J Pediatr Gastroenterol Nutr 2002; 34 (4) 372-377
    CrossrefPubMedGoogle Scholar
  • 42 Wald A. Constipation, diarrhea, and symptomatic hemorrhoids during pregnancy. Gastroenterol Clin North Am 2003; 32 (1) 309-322, vii
    CrossrefPubMedGoogle Scholar
  • 43 Tytgat GN, Heading RC, Müller-Lissner S , et al. Contemporary understanding and management of reflux and constipation in the general population and pregnancy: a consensus meeting. Aliment Pharmacol Ther 2003; 18 (3) 291-301
    CrossrefPubMedGoogle Scholar
  • 44 Nardulli G, Limongi F, Sue G, Zapata L, Bompart I. [Use of polyethylene glycol in the treatment of puerperal constipation]. G E N 1995; 49 (3) 224-226
    PubMedGoogle Scholar